FDA authorizes JUUL2 system in the U.S.
The FDA authorized the JUUL2 system for sale in the U.S., approving tobacco-and-menthol-flavored pods with 1.6% nicotine.Summary
On August 27, 2026, the U.S. Food and Drug Administration (FDA) granted marketing authorization for the JUUL2 system, covering tobacco-and-menthol-flavored pods with 1.6% nicotine concentration. This decision follows a review of Premarket Tobacco Product Applications (PMTAs) submitted in 2023, which included non-clinical, clinical, behavioral, and population science data. The FDA determined the device meets statutory standards for public health protection. The authorization serves as a regulatory benchmark for smoke-free nicotine products in markets like Canada, where convenience store operators monitor U.S. decisions. In 2023, Juul Labs settled for $462 million in the U.S. over its role in youth vaping. The Juul2 system introduces safety features, including an optional 21-plus smartphone app that provides usage insights, device location, battery tracking, and pod-level information, and allows users to lock the device to prevent unauthorized use.
(Source：CCentral)
